HT
LUMO

HAP Trading’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

HAP Trading’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,039
Closed -$1.53M – 1206
2017
Q1 		$1.53M Buy
+7,039
New +$1.01M 0.09% 175
2016
Q4 		– Sell
-33,103
Closed -$3.73M – 1263
2016
Q3 		$4.47M Buy
33,103
+7,800
+31% +$775K 0.16% 80
2016
Q2 		$2.56M Buy
25,303
+16,803
+198% +$2.08M 0.15% 117
2016
Q1 		$1.39M Buy
8,500
+6,755
+387% +$1.37M 0.1% 167
2015
Q4 		$571K Buy
1,745
+440
+34% +$143K 0.03% 358
2015
Q3 		$421K Buy
+1,305
New +$573K 0.02% 396
2015
Q2 		– Sell
-1,801
Closed -$765K – 1184
2015
Q1 		$887K Sell
1,801
-654
-27% -$253K 0.06% 260
2014
Q4 		$878K Sell
2,455
-20,705
-89% -$6.16M 0.03% 356
2014
Q3 		$4.46M Buy
+23,160
New +$5.09M 0.18% 98

Other funds holding LUMO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
IFG
Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HAP Trading's LUMO Position: Q2 2017 in Review

HAP Trading sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2017, closing a stake of 7,039 shares — an estimated $1.53M sold.

HAP Trading first reported a position in LUMO in Q3 2014 and held it in 9 quarters. The position peaked at $4.47M in Q3 2016. 110 funds tracked by Wall St. Rank hold LUMO as of Q2 2017.

  • HAP Trading reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • HAP Trading sold 7,039 Lumos Pharma, Inc. Common Stock shares in Q2 2017, an estimated $1.53M.
  • HAP Trading first reported a position in Lumos Pharma, Inc. Common Stock in Q3 2014 and held it in 9 quarters.
  • HAP Trading's Lumos Pharma, Inc. Common Stock position peaked at $4.47M in Q3 2016.
  • 110 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2017.

Based on HAP Trading's 13F filing for Q2 2017, filed 10 Aug 2017.